pubmed-article:12668010 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12668010 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:12668010 | lifeskim:mentions | umls-concept:C0033384 | lld:lifeskim |
pubmed-article:12668010 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
pubmed-article:12668010 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
pubmed-article:12668010 | lifeskim:mentions | umls-concept:C0624284 | lld:lifeskim |
pubmed-article:12668010 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:12668010 | pubmed:dateCreated | 2003-4-1 | lld:pubmed |
pubmed-article:12668010 | pubmed:abstractText | Analogues of the naturally occurring cyclic hydroxamate dealanylalahopcin, which is an inhibitor of procollagen prolyl-4-hydroxylase, were synthesised and shown to be inhibitors of the human hypoxia-inducible factor prolyl hydroxylases. | lld:pubmed |
pubmed-article:12668010 | pubmed:language | eng | lld:pubmed |
pubmed-article:12668010 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12668010 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12668010 | pubmed:month | Apr | lld:pubmed |
pubmed-article:12668010 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:SchofieldChri... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:HewitsonKirst... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:RatcliffePete... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:McNeillLuke... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:PughChristoph... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:TianYa-MinYM | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:MoleDavid RDR | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:SchlemmingerI... | lld:pubmed |
pubmed-article:12668010 | pubmed:author | pubmed-author:DhandaAnupmaA | lld:pubmed |
pubmed-article:12668010 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12668010 | pubmed:day | 17 | lld:pubmed |
pubmed-article:12668010 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:12668010 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12668010 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12668010 | pubmed:pagination | 1451-4 | lld:pubmed |
pubmed-article:12668010 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:meshHeading | pubmed-meshheading:12668010... | lld:pubmed |
pubmed-article:12668010 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12668010 | pubmed:articleTitle | Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. | lld:pubmed |
pubmed-article:12668010 | pubmed:affiliation | Oxford Centre for Molecular Sciences, Dyson Perrins Laboratory, South Parks Road, UK. | lld:pubmed |
pubmed-article:12668010 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12668010 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:12668010 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12668010 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12668010 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12668010 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12668010 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12668010 | lld:pubmed |